Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[CLINICAL AND PHARMACOLOGICAL FACTORS INFLUENCING RESISTANCE TO CLOPIDOGREL IN PATIENTS WITH CARDIOVASCULAR DISEASES].

Klinicheskaia meditsina - 1 Jan 2015

Mesitskaia D F, Nikitina Iu M, Kopylov F Iu, Syrkin A L, Aksenova M G, Kirillov M Iu, Dobrovol'skiĭ A V

Abstract excerpt

We analysed clinical and pharmacological factors influencing resistance to clopidogrel in 250 patients with cardiovascular diseases during 18 months. It was shown that the risk ofresistance depends on the form of coronary heart disease, carbohydrate metabolism, the AA genotype of CYP2C19*2 and TBS1 genes. The cardiovascular events significantly morefrequently occurred during 12 and 18 months in resistant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Clopidogrel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C19

Share to Drug Resistance

Share to Platelet Aggregation Inhibitors

Share to Polymorphism, Genetic

Share to Ticlopidine

Source

Identifiers

PMID: 26117917

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[CLINICAL AND PHARMACOLOGICAL FACTORS INFLUENCING RESISTANCE TO CLOPIDOGREL IN PATIENTS WITH CARDIOVASCULAR DISEASES].PMID 26117917Read ↗

The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD).Semantic proximity Read ↗

[Effects of clopidogrel resistence and CYP2C19 genotype on the clinical prognosis of patients with acute coronary syndrome undergoing percutaneous coronary intervention].Semantic proximity Read ↗

[Clopidogrel resistance--risk factor in patients with acute coronary syndromes].Semantic proximity Read ↗

[Factors determining clinical effectiveness of clopidogrel and prognosis of patients with stable ischemic heart disease].Semantic proximity Read ↗

[Clinical impact and underlying mechanism of clopidogrel response variability].Semantic proximity Read ↗

Factors that contribute to clopidogrel resistance in cardiovascular disease patients: environmental and genetic approach.Semantic proximity Read ↗

Dynamic changes and associated factors of clopidogrel resistance in patients after cerebral infarction.Semantic proximity Read ↗

[Association of ITGB3, P2RY12, and CYP2C19 gene polymorphisms with platelet functional activity in patients with coronary heart disease during dual antiplatelet therapy].Semantic proximity Read ↗

Construction of a Machine Learning-Based Clopidogrel Resistance Risk Prediction Model.Semantic proximity Read ↗

[Association between clopidogrel resistance and polymorphism of platelet adenosine diphosphate receptor in patients with coronary atherosclerotic disease].Semantic proximity Read ↗

Review of aspirin and clopidogrel resistance in peripheral arterial disease.Semantic proximity Read ↗

Single nucleotide polymorphism of CYP3A5*3 contributes to clopidogrel resistance in coronary artery disease patients among Tamilian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.